CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Comprehensive Immunophenotypic Profiling and Prognostic Value in Salivary Gland Mucoepidermoid Carcinoma.
Comprehensive Immunophenotypic Profiling and Prognostic Value in Salivary Gland Mucoepidermoid Carcinoma.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
在 MEC 中观察到的异质性免疫表型谱反映了 TME 的生物学复杂性。Ki-67 被发现是肿瘤增殖活性的可靠指标和不良预后因素。高 Ki-67 表达、CK19 缺失和 TIL 密度升高与复发风险增加相关。尽管 Pan-TRK 表达不常见且无预后相关性,但其在高增殖性肿瘤中的出现提示可能存在生物学相互作用。将免疫表型分析扩展至纳入空间分析和单细胞水平表征,可能加深我们对 MEC 发病机制的理解,并支持个性化治疗策略。
描述唾液腺黏液表皮样癌(MEC)的增殖和免疫表型特征,并探讨其与临床病理特征、肿瘤微环境(TME)特征、Pan-TRK 表达及疾病预后的关联。
对41例MEC病例进行了Ki-67、细胞角蛋白19(CK19)、水通道蛋白5(AQP5)、CD3、CD8和Pan-TRK的免疫组化检测。将临床病理参数与蛋白表达模式进行相关性分析,以评估肿瘤行为和潜在的TRK融合活性。
Ki-67表达升高与侵袭性组织学特征和不良临床结局相关。CK19表达在高分级(HG)MEC中显著降低,其缺失与不良预后相关。高TIL(肿瘤浸润淋巴细胞)密度与风险增加相关,而预后不良的病例表现出异质性的CD3和CD8 T细胞谱。Pan-TRK表达仅在5例(12.2%)中检测到,通常较弱且异质性,与癌症复发风险无稳健相关性。
To characterize the proliferative and immunophenotypic profiles of salivary gland mucoepidermoid carcinoma (MEC) and to explore their associations with clinicopathologic features, tumour microenvironment (TME) characteristics, Pan-TRK expression, and disease prognosis.
Forty-one MEC cases were examined using immunohistochemistry for Ki-67, Cytokeratin 19 (CK19), Aquaporin 5 (AQP5), CD3, CD8, and Pan-TRK. Clinicopathologic parameters were correlated with protein expression patterns to assess tumour behaviour and potential TRK fusion activity.
Elevated Ki-67 expression correlated with aggressive histologic features and poor clinical outcomes. CK19 expression was significantly reduced in high-grade (HG) MECs, and its loss was associated with unfavourable prognosis. High tumour-infiltrating lymphocyte density correlated with an increased risk, while cases with poor outcomes exhibited heterogeneous CD3 and CD8 T-cell profiles. Pan-TRK expression was detected in only five cases (12.2%), typically weak and heterogeneous, and no robust correlation with cancer recurrence risk was present.
The heterogeneous immunophenotypic profiles observed in MEC reflect the biological complexity of the TME. Ki-67 was found to be a reliable indicator of tumour proliferative activity and an unfavourable prognosis. High Ki-67 expression, loss of CK19, and elevated TIL density were associated with increased recurrence risk. Although Pan-TRK expression was infrequent and not prognostically relevant, its occurrence in highly proliferative tumours suggests possible biologic interplay. Expanding immunophenotypic profiling to incorporate spatial analyses and single-cell-level characterization may deepen our understanding of MEC pathogenesis and support personalized therapeutic strategies.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。